Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/04/2003WO2003072784A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/04/2003WO2003072782A1 Echinococcus antigen, gene encoding the same and method of diagnosing human hydatidosis
09/04/2003WO2003072781A1 Mite galectin
09/04/2003WO2003072780A1 Novel proteins, dnas thereof and use of the same
09/04/2003WO2003072779A1 Method of using pituitary-specific genes
09/04/2003WO2003072777A1 Embryonically modified animal and method of constructing the same
09/04/2003WO2003072776A1 Gene encoding novel enzyme catalyzing glycosyl transfer reaction and process for producing the enzyme
09/04/2003WO2003072775A1 Alga-origin promoter, intron and terminator
09/04/2003WO2003072774A1 K+ transporter and use thereof
09/04/2003WO2003072772A1 Stimulus-responsive dna organization
09/04/2003WO2003072771A2 Method of preparing a treatment product using a togaviridae expression construct
09/04/2003WO2003072770A1 Novel dehydrogenase and gene encoding the same
09/04/2003WO2003072766A1 Anti-ccr5 antibody
09/04/2003WO2003072763A1 Increasing plant seed production
09/04/2003WO2003072761A1 20 human secreted proteins
09/04/2003WO2003072760A2 Method for cloning and expression of bsawi restriction endonuclease and bsawi methylase in e. coli
09/04/2003WO2003072758A2 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity
09/04/2003WO2003072755A2 Transgenic zebrafish models for thrombosis
09/04/2003WO2003072750A2 Expression of hiv-related proteins in plants
09/04/2003WO2003072746A2 Subtilisin carlsberg proteins with reduced immunogenicity
09/04/2003WO2003072745A2 Antigene locks and therapeutic uses thereof
09/04/2003WO2003072743A2 Method for the recombination of genetic elements
09/04/2003WO2003072741A2 Therapeutic regulation of deoxyribonuclease-1-like-3 activity
09/04/2003WO2003072740A2 Novel type-1 cytokine receptor glm-r
09/04/2003WO2003072739A2 Trans-splicing mediated imaging of gene expression
09/04/2003WO2003072736A2 Reagents and treatment methods for autoimmune diseases
09/04/2003WO2003072733A2 Modified bace
09/04/2003WO2003072732A2 Methods of making hypermutable cells using pmsr homologs
09/04/2003WO2003072730A2 Secondary metabolite congener distribution modulation
09/04/2003WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
09/04/2003WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/04/2003WO2003072715A2 Gasp1: a follistatin domain containing protein
09/04/2003WO2003072714A2 Follistatin domain containing proteins
09/04/2003WO2003072711A2 Method of using modified oligonucleotides for hepatic delivery
09/04/2003WO2003072708A2 Pluripotent cells comprising allogenic nucleus and mitochondria
09/04/2003WO2003072705A2 Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina)
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072703A2 Adenoviral vector with replication-dependent transgene expression
09/04/2003WO2003072702A2 Merhod for cloning and expression of mspa1i restriction endonuclease and mspa1i methylase in e. coli
09/04/2003WO2003072700A2 Androgen receptor overexpressing skeletal myoblasts
09/04/2003WO2003072637A1 Carbohydrate-modified polymers, compositions and uses related thereto
09/04/2003WO2003072609A1 Tick chitinase
09/04/2003WO2003072608A1 Anti-human tenascin monoclonal antibody
09/04/2003WO2003072603A2 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
09/04/2003WO2003072602A2 Protein complexes and methods for their use
09/04/2003WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
09/04/2003WO2003072600A2 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53
09/04/2003WO2003072594A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
09/04/2003WO2003072591A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications
09/04/2003WO2003072590A1 Rna interference mediated inhibition of map kinase genes
09/04/2003WO2003072586A2 Methods of producing phosphitylated compounds
09/04/2003WO2003072542A2 Interfacial biomaterials
09/04/2003WO2003072256A1 Holding tray having through-hole wells
09/04/2003WO2003072240A1 Apparatus for treatment of light-sensitive biopolymers
09/04/2003WO2003072228A1 Process for preparing processed sample liquid solution for electrophoresis
09/04/2003WO2003072127A1 Method for drying water-borne materials
09/04/2003WO2003072114A1 Vascular therapeutics
09/04/2003WO2003072065A2 Drug signatures
09/04/2003WO2003072054A2 Custom ligand design for biomolecular filtration and purification for bioseperation
09/04/2003WO2003072051A2 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same
09/04/2003WO2003072045A2 Treatment and prevention of aids progression and methods of using same
09/04/2003WO2003072041A2 Assays to monitor amyloid precursor protein processing
09/04/2003WO2003072036A2 Treatment methods using anti-cd22 antibodies
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072014A2 Minicell compositions and methods
09/04/2003WO2003072012A2 Oral dna composition for hepatitis b virus chronic infection
09/04/2003WO2003071933A2 Novel compositions and methods for cancer
09/04/2003WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003WO2003071861A2 Vanillin biosynthetic pathway enzyme from vanilla planifolia
09/04/2003WO2003071860A2 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage
09/04/2003WO2003071859A2 Methods for increasing the amount of protein in potato tubers
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003054007A3 Streptococcus antigens
09/04/2003WO2003053224A3 Novel compositions and methods for cancer
09/04/2003WO2003051926A3 Anti-cd7 immunotoxin as fusion protein
09/04/2003WO2003044187A3 Emulsion compositions
09/04/2003WO2003041491A3 Doubled haploid production and genetic transformation
09/04/2003WO2003040379A3 Modulating urea degradation in wine yeast
09/04/2003WO2003040297A3 New protein of the defensin family from oil palm
09/04/2003WO2003039438A3 Pna-conjugates for treating chronic myeloid leukaemia (cml)
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003027297A9 PROCESS FOR PRODUCING α2,3/α2,8-SIALYLTRANSFERASE AND SIALIC ACID-CONTAINING COMPLEX SUGAR
09/04/2003WO2003025151A3 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
09/04/2003WO2003024999A3 THE F-BOX PROTEIN hCdc4 TARGETS CYCLIN E FOR UBIQUITINYLATION AND DEGRADATION
09/04/2003WO2003022867A3 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
09/04/2003WO2003018818A3 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
09/04/2003WO2003018765A3 A high throughput method for identification of sequence tags
09/04/2003WO2003017753A3 Reverse breeding
09/04/2003WO2003014366A3 Rna amplification system using plant components in animal cells
09/04/2003WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof
09/04/2003WO2003013647A3 Electrodes coated with treating agent and uses thereof
09/04/2003WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
09/04/2003WO2003008616A3 PROCESS FOR THE PREPARATION OF L-AMINO ACIDS USING STRAINS OF THE ENTEROBACTERIACEAE FAMILY WHICH CONTAIN AN ATTENUATED aceK GENE
09/04/2003WO2003004525A8 Isolation and purification of plasmodium falciparum merozoite protein-142
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2003000882A3 Transgenic models for glucose homeostasis comrpising human gsk-3
09/04/2003WO2002103016A3 Human tachykinin-related splice variants and compositions thereof
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
1 ... 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 ... 4023